Caitong International Asset Management’s Minerva Neurosciences NERV Stock Holding History

Caitong International Asset Management’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39	Buy	+7	New	+$38	﹤0.01%	2396

Other funds holding NERV

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Caitong International Asset Management's NERV Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Minerva Neurosciences (NERV) in Q2 2026: 7 shares worth $39. The stake represents ﹤0.01% of the portfolio and ranks #2396 among its holdings.

11 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

Caitong International Asset Management held 7 shares of Minerva Neurosciences worth $39 as of Q2 2026.
Minerva Neurosciences was a new Caitong International Asset Management position in Q2 2026.
Minerva Neurosciences made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2396 holding.
11 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.